This study demonstrated that DDX60 is highly expressed in GBM and predicts poor prognosis of glioma by the Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), Repository for Molecular Brain Neoplasia Data (REMBRANDT), and Gravendeel databases. Here, DDX60 is linked to central nervous system cancer.